Clinical Trials · NCT03944434
FACILE: FeAsibility of First-line RiboCIclib in OLdEr Patients with Advanced Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Fondazione Sandro Pitigliani
- Enrollment
- 116
- Start date
- Dec 2018
- Locations
- 1 site, Italy
- Primary endpoint
- Treatment feasibility